Los Angeles, California 90027

  • Acute HIV Infection

Purpose:

Specimen Repository for HIV Immunopathogenesis Studies


Study summary:

The goal is to build a large specimen repository for collaborating scientists to run studies of immunity and HIV-1.


Criteria:

Inclusion Criteria: 1. HIV positive (acutely infected, viremic and elite controllers) 2. Signed Informed Consent Form 3. Age at least 18 years old 4. Immune controllers, two types: "Elite suppressors" (HIV-positive with any three consecutive plasma HIV-1 RNA PCR undetectable while off treatment) or "viremic suppressors" (HIV-positive with any three consecutive HIV-1 RNA PCR <3000 while off treatment). 5. Acutely infected subjects: Persons identified to have a negative HIV antibody response (ELISA) but positive detection of HIV-1 in the blood (RT-PCR) or individuals who have evidence of a recent (past 30 days) HIV negative result along with a current HIV positive result. Exclusion Criteria: 1. Uncontrolled bleeding diathesis. 2. Pregnant. 3. Inability to provide informed consent.


NCT ID:

NCT03579381


Primary Contact:

Study Director
Otto O Yang, MD
Scientific Director


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90027
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 24, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.